We are live on ! Find out more
FO

FT Options Portfolio holdings

AUM $66.4M
1-Year Est. Return 18.48%
This Fund
S&P 500
This Quarter Est. Return
-1.61%
1 Year Est. Return
+18.48%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$116M
AUM Growth
+$21M
Cap. Flow
+$284M
Cap. Flow %
244.1%
Top 10 Hldgs %
42.12%
Holding
462
New
171
Increased
79
Reduced
68
Closed
122

Top Buys

Rank Stock Value
1
MDVN
MEDIVATION, INC.
MDVN
+$4.59M
2
BIIB icon
Biogen
BIIB
+$3.56M
3
CALM icon
Cal-Maine
CALM
+$2.79M
4
BMY icon
Bristol-Myers Squibb
BMY
+$2.48M
5
AAPL icon
Apple
AAPL
+$2.33M

Top Sells

Rank Stock Value
1
BAX icon
Baxter International
BAX
+$4.11M
2
GILD icon
Gilead Sciences
GILD
+$2M
3
IBM icon
IBM
IBM
+$1.48M
4
CMG icon
Chipotle Mexican Grill
CMG
+$930K
5
EXPE icon
Expedia Group
EXPE
+$914K

Sector Composition

Rank Sector Weight
1 Healthcare 41.4%
2 Technology 6.27%
3 Consumer Staples 4.14%
4 Consumer Discretionary 2.26%
5 Materials 1.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ENDP
276
CALL
DELISTED
Endo International plc
ENDP
$14K 0.01%
10,000
-10,000
-50% -$207K
AKBA icon
277
CALL
Akebia Therapeutics
AKBA
$359M
$13K 0.01%
35,000
+2,700
+8% +$23.6K
ORCL icon
278
CALL
Oracle
ORCL
$364B
$13K 0.01%
+20,000
New +$799K
QCOM icon
279
CALL
Qualcomm
QCOM
$181B
$13K 0.01%
+5,000
New +$263K
WDC icon
280
PUT
Western Digital
WDC
$164B
$12K 0.01%
15,545
-1,786
-10% -$58.8K
SPLK
281
CALL
DELISTED
Splunk Inc
SPLK
$12K 0.01%
+26,100
New +$1.38M
AET
282
CALL
DELISTED
Aetna Inc
AET
$12K 0.01%
+12,500
New +$1.44M
LLTC
283
CALL
DELISTED
Linear Technology Corp
LLTC
$12K 0.01%
5,600
-11,900
-68% -$544K
RMBS icon
284
PUT
Rambus
RMBS
$11B
$11K 0.01%
5,200
– –
SPY icon
285
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$774B
$11K 0.01%
+7,000
New +$1.45M
ATVI
286
PUT
DELISTED
Activision Blizzard
ATVI
$11K 0.01%
+35,000
New +$1.29M
MAT icon
287
PUT
Mattel
MAT
$4.16B
$10K 0.01%
+4,000
New +$127K
ORCL icon
288
PUT
Oracle
ORCL
$364B
$10K 0.01%
+30,000
New +$1.2M
POT
289
CALL
DELISTED
Potash Corp Of Saskatchewan
POT
$10K 0.01%
20,000
-15,000
-43% -$251K
CELG
290
CALL
DELISTED
Celgene Corp
CELG
$10K 0.01%
+25,000
New +$2.59M
OPK icon
291
PUT
Opko Health
OPK
$899M
$9K 0.01%
+12,200
New +$124K
XLNX
292
CALL
DELISTED
Xilinx Inc
XLNX
$9K 0.01%
56,400
+41,400
+276% +$1.89M
CHTR icon
293
PUT
Charter Communications
CHTR
$16.2B
$8K 0.01%
+1,324
New +$285K
KLAC icon
294
CALL
KLA
KLAC
$278B
$8K 0.01%
+49,000
New +$351K
DD icon
295
CALL
DuPont de Nemours
DD
$18.3B
$7K 0.01%
11,846
-2,567
-18% -$338K
RGLS
296
CALL
DELISTED
Regulus Therapeutics
RGLS
$7K 0.01%
797
+214
+37% +$153K
CLVS
297
CALL
DELISTED
Clovis Oncology, Inc.
CLVS
$7K 0.01%
24,400
-5,200
-18% -$76K
MNDT
298
CALL
DELISTED
Mandiant, Inc. Common Stock
MNDT
$7K 0.01%
+18,000
New +$291K
CLDX icon
299
Celldex Therapeutics
CLDX
$2.77B
$6K 0.01%
+87
New +$5.52K
EXAS
300
PUT
DELISTED
Exact Sciences
EXAS
$6K 0.01%
+20,000
New +$151K
10 11
12
13 14

Similar funds

MC
Micawber Capital Seattle, Washington $62.9M AUM 20.32% 1-Year Est. Return
FIM
Friedberg Investment Management Houston, Texas $61.9M AUM 20.07% 1-Year Est. Return
TLIC
Thai Life Insurance Company Bangkok, Thailand $71M AUM 20.14% 1-Year Est. Return
MKCM
Mount Kellett Capital Management New York $61M AUM 12.22% 1-Year Est. Return
ACM
Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return
MFM
Marianas Fund Management New York $58.1M AUM 10.84% 1-Year Est. Return
VE
Vega Energy New York $75.5M AUM 15.36% 1-Year Est. Return
GFWEV
G.F.W. Energy VIII Irving, Texas $76.3M AUM 11.41% 1-Year Est. Return

FT Options's Q2 2016 Portfolio in Review

As of Q2 2016, FT Options held 462 positions worth $116M, up 22% from $95.5M the previous quarter. Its ten largest holdings account for 42% of the portfolio.

FT Options deployed $284M of net new capital in Q2 2016, opening 171 new positions and adding to 79 existing holdings. Its largest new stake was Bristol-Myers Squibb: 35,075 shares worth $2.58M.

By sector, the portfolio is most concentrated in Healthcare at 41% of assets, down from 48% a quarter earlier, followed by Technology and Consumer Staples.

On the sell side, the largest reduction was Gilead Sciences, an estimated $2M trimmed.

  • FT Options's largest Q2 2016 buy was Bristol-Myers Squibb: 35,075 shares worth $2.58M.
  • FT Options added most to MEDIVATION, INC. in Q2 2016, an estimated $4.59M increase.
  • FT Options's biggest Q2 2016 reduction was Gilead Sciences, cutting an estimated $2M.
  • FT Options fully exited Baxter International in Q2 2016, selling an estimated $4.11M.
  • FT Options's ten largest holdings make up 42% of its $116M portfolio in Q2 2016.
  • FT Options opened 171 new positions and closed 122 in Q2 2016.
  • FT Options's portfolio value rose 22% quarter-over-quarter to $116M.

Based on FT Options's 13F filing for Q2 2016, filed 12 Aug 2016.